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https://doi.org/10.1016/j.stemcr.2017.11.018SUMMARYIn vivo hematopoietic generation occurs in waves of primitive and definitive cell emergence. Differentiation cultures of pluripotent em-
bryonic stem cells (ESCs) offer an accessible source of hematopoietic cells for blood-related research and therapeutic strategies. However,
despitemany approaches, it remains a goal to robustly generate hematopoietic progenitor and stem cells (HP/SCs) in vitro from ESCs. This
is partly due to the inability to efficiently promote, enrich, and/ormolecularly direct hematopoietic emergence. Here, we useGata2Venus
(G2V) and Ly6a(SCA1)GFP (LG) reporter ESCs, derived from well-characterized mouse models of HP/SC emergence, to show that during
in vitro differentiation they report emergent waves of primitive hematopoietic progenitor cells (HPCs), definitive HPCs, and B-lymphoid
cell potential. These results, facilitated by enrichment of single and double reporter cells with HPC properties, demonstrate that in vitro
ESC differentiation approximates the waves of hematopoietic cell generation found in vivo, thus raising possibilities for enrichment of
rare ESC-derived HP/SCs.INTRODUCTION
Since the first report of blood cell production from embry-
onic stem cells (ESCs) (Doetschman et al., 1985), it has
been a long-term goal to use in vitro cultures to produce
definitive hematopoietic progenitor cells (HPCs) and he-
matopoietic stem cells (HSCs). With the advent of pa-
tient-specific induced pluripotent stem cells (iPSCs), this
approach could be used for treating blood disorders
without the adverse effects of rejection. Some progress to-
ward differentiation into distinct blood lineages has been
made through addition of growth factors to ESC/iPSC dif-
ferentiation cultures (Doulatov et al., 2013; Kennedy
et al., 2012; Pearson et al., 2015), and limited in vivo repo-
pulation has been achieved by overexpression of transcrip-
tion factors in ESCs/iPSCs/endothelial cells (Lis et al., 2017;
Sugimura et al., 2017). More fundamental studies on ESC
hematopoietic differentiation have provided some insight
into whether such ex vivo cultures recapitulate in vivo he-
matopoietic development (Choi et al., 1998; Huber et al.,
2004; Lancrin et al., 2009).
The natural development of the hematopoietic system
occurs in spatiotemporally distinct waves (reviewed in
Dzierzak and Speck, 2008; Kauts et al., 2016). The first
blood cell production occurs in the yolk sac (YS) at mouse
embryonic day 7 (E7), producing a transient cell popula-
tion of mainly primitive erythrocytes (Palis et al., 1999).
Definitive erythrocytes and myeloid cells appear in the YS
starting at E8.25 and originate from erythroid-myeloid pro-
genitors (EMPs) (Frame et al., 2013). Shortly thereafter,
HPCs with erythroid-myeloid-lymphoid potential (GodinStem Cell R
This is an open access article under the Cet al., 1995), lymphoid progenitors (Boiers et al., 2013; Li
et al., 2014), and neonatal-engrafting hematopoietic cells
arise (Yoder et al., 1997). HSC production is initiated in
the final wave starting at E10.5 in the aorta-gonads-meso-
nephros (AGM) (Medvinsky and Dzierzak, 1996; Muller
et al., 1994).
The Gata2 transcription factor plays a pivotal intrinsic
role in EMP, HPC, and HSC generation in the embryo (de
Pater et al., 2013; Gao et al., 2013; Ling et al., 2004; Tsai
et al., 1994). Gata2/ mouse and human (h) ESCs show
defective hematopoietic differentiation (Huang et al.,
2015; Tsai et al., 1994), and most hESC-derived HPCs are
marked byGATA2 reporter expression, although it is uncer-
tain whether this reporter parallels endogenous GATA2
expression (Huang et al., 2016). In our Gata2Venus (G2V)
mice, in which levels of Gata2 expression are normal, it
was found that Gata2 marks all HSCs and majority of
HPCs. Gata2 is expressed in endothelial cells of the E8.5
YS and dorsal aorta (Minegishi et al., 1999; Robert-Moreno
et al., 2005), E10.5 aortic hemogenic endothelial cells
(HECs) (Eich et al., 2017), and C-KIT+CD31+ intra-aortic
hematopoietic cluster cells (IAHCs) (Kaimakis et al.,
2016). Thus, the G2V reporter facilitates the examination
of HPCs and HSCs as they emerge in the mouse embryo.
Ly6a(SCA1)GFP (LG) is another reporter that marks embry-
onic aortic cells. All HSCs, some HECs, IAHCs (Chen et al.,
2011; de Bruijn et al., 2002; Li et al., 2014; Solaimani Karta-
laei et al., 2015), and embryonic cells with lymphoid
potential (de Bruijn et al., 2002; Li et al., 2014) are LG
expressing. Vital imaging of the E10.5 mouse aorta
shows endothelial-to-hematopoietic transition (EHT) ofeports j Vol. 10 j 151–165 j January 9, 2018 j ª 2017 The Author(s). 151
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. G2V-Expressing Cells in Early Differentiation Culture Possess Primitive Erythroid and Endothelial Potential
(A) Scheme of ESC differentiation. BMP4 was present on days 0–3. FACS-analyzed/sorted embryoid body (EB) cells were tested in CFU-C
(colony-forming unit—cell) and Matrigel assays.
(B) Dot plots for FLK1 (F) and Venus (V) expression from day 3 (d3) to day 6 (n = 3).
(C) Quantification of FACS data in (B) showing percentage of F+V, F+V+, and FV+ cells at days 3–6 (n = 3).
(D) Bar graphs showing CFU-C/104 F+V, F+V+, FV+, and FV cells at days 4–6 (n = 4). Colony types are indicated by color. CFU-M,
macrophage; BFU-E, definitive erythroid; CFU-EryP, primitive erythroid.
(legend continued on next page)
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these cells (Boisset et al., 2010). However, unlike the G2V
reporter, LG+ cells are found in the AGM only beginning
at late E9 (Mascarenhas et al., 2009), and thus, this distin-
guishes the later induction of an intraembryonic definitive
HPC/HSC program.
Taking into account the complex spatiotemporal organi-
zation of in vivo blood development, it is likely that the abil-
ity to robustly generate definitive HPC/HSC in vitro de-
pends on the spatiotemporal programs occurring during
ESC differentiation, and requires enrichment methodolo-
gies with pivotal reporters to identify/isolate the cells of in-
terest. Such reporters are a powerful tool for studying the
dynamics of functional HPC/HSC generation in vitro
(Huber et al., 2004; Lancrin et al., 2009; Ng et al., 2016)
and their relationship to normal HPC/HSC development.
Here we examine the expression ofG2V and LG reporters
and the emergence of functional hematopoietic cells in a
stepwise in vitro system of induction, enrichment, and dif-
ferentiation of ESCs. We show that the temporal wave-like
G2V reporter expression corresponds to waves of primitive
and definitive hematopoietic emergence. Gata2 is co-ex-
pressed in these cells with hematopoietic transcription fac-
tors andmarks functional HPCs emerging in the sequential
waves. LG expression is specific to HPCs that emerge/
persist in later differentiation stages, marking definitive
progenitors with erythroid, myeloid, and/or B-lymphoid
potential. This is confirmed in double reporter ESCs to
show that in vitro differentiation occurs in stages that
approximate the in vivo hematopoietic cell generation in
mouse embryos.RESULTS
Hematopoietic and Endothelial Potential of Gata2+
ESCs
Hematopoiesis is initiated by FLK1+ cells, which are able to
generate endothelial and hematopoietic progenitors (Choi
et al., 1998; Huber et al., 2004). In hESC differentiation cul-
tures, KDR+ cells develop in response to bone morphoge-
netic protein 4 (BMP4) between 72 and 96 hr and represent
a transient population that precedes the onset of primitive
hematopoiesis (Kennedy et al., 2007). To directly examine
the relationship of Gata2 expression and hematopoietic
differentiation of mouse ESCs, we used a G2V reporter
ESC line (Kaimakis et al., 2016) that facilitates tracing and
isolation of live Gata2+ cells by Venus fluorescence (Fig-
ure S1), while preserving normal Gata2 endogenous levels.(E) Representative images showing endothelial tubules in Matrigel cu
ESCs. Scale bars, 200 mm.
(F) Quantification of (E) (tubules/2 3 104 cells; n = 3).
Data are shown as means ± SEM. See also Figure S1.This is critical, since altered Gata2 levels severely affect the
production and expansion of embryonic HSCs and HPCs
and affect HSC robustness in the adult (Ling et al., 2004;
Rodrigues et al., 2005), and dysregulation leads to leukemic
syndromes (Katsumura et al., 2017). To examine whether
Gata2+ cells possess endothelial or hematopoietic cell char-
acteristics, we inducedG2V ESC differentiation in the pres-
ence of BMP4 (Figure 1A) and analyzed them at days 3–6.
FLK1+V, FLK1V+, FLK1+V+, and FLK1V cells sorted by
fluorescence-activated cell sorting (FACS) were evaluated
in hematopoietic colony-forming unit—cell (CFU-C) and
Matrigel endothelial assays.
At days 3 and 4, the majority of V+ cells co-expressed
FLK1 (67% and 76%, respectively) (Figure 1B). As the
FLK1+V+ cell frequency decreased at day 5, the V+ single
positive population became more prominent and FLK1+
cell frequency decreased (Figure 1C). Only the V+ fraction
produced CFU-C (Figure 1D). CFU-Cs were detected from
day 4 onward, with the main colony type being CFU-
EryP (—primitive erythroid). Few CFU-M (—macrophages)
and burst-forming units—definitive erythroid (BFU-E) pro-
genitors were observed. Although the majority of colonies
were scored in the FLK1V+ population (24 ± 13, 16 ± 11,
and 23.2 ± 10 CFU-C/104 cells at days 4, 5, and 6, respec-
tively), CFU-C were also detected in the FLK1+V+ cells at
day 4.
To test the day-4 endothelial potential of ESCs (time
of highest CFU-C potential in FLK1+V+ fraction), we
quantified tubule formation of sorted cells (Figures 1E
and 1F). The highest frequency was in FLK1+V cells
(100 tubules/2 3 104 cells). FLK1+V+ cells also showed
endothelial potential (30 tubules/2 3 104 cells), demon-
strating that in addition to hematopoietic potential, some
FLK1+V+ cells are capable of endothelial differentiation.
This transient Gata2-expressing FLK1+ population emerges
at day 4 and rapidly decreases thereafter. Thus, Gata2-ex-
pressing FLK1+ cells give rise to the earliest blood cells.Temporally Defined Gata2 Expression Waves Are
Detected in ESC Cultures
The temporal dynamics of Gata2 expression was character-
ized in ESC hematopoietic differentiation from days
4 to 14 by FACS (Figures 2 and S1D). V+ cells were
detected throughout the time course and showed wave-
like dynamics with peaks of increased V+ cell frequency.
Compared with day 4, day-6 V+ cell percentages
were significantly higher (5.5-fold) (Figure 2A) and thenltures of F+V, F+V+, FV+, and FV cells from day-4 differentiated
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decreased at days 7–10. V+ cell percentages increased again
at day 11, decreased at day 13, and increased again at day 14
(RNA analysis in Figure S1E). Gata2 RNA expression (Fig-
ure 2B) showed increases at days 6 and 14 that correspond
with the V+ cell frequency (Figure 2A; no Gata2 RNA anal-
ysis performed at day 11). To exclude the possibility that
the later Gata2 expression peaks are due to the remaining
undifferentiated ESCs, we analyzed the expression of the
Nanog pluripotency factor. Nanog RNA was significantly
decreased after day 3 of differentiation and no protein
was detected at d12 (Figures S1F and S1G). Also, Brachyury
expression, indicative of primitive streak/mesoderm,
showed the expected dynamics with increased expression
at days 3–6, andwas downregulated thereafter (Figure S1H),
thus supporting the likelihood of independent induction
waves of Gata2+ hematopoietic cells in ESC cultures.
Gata2 functions in combinationwith other key (heptad)
hematopoietic transcription factors to direct HPC/HSC
development (Wilson et al., 2010). The expression of
Gata2, Tal1, Lyl1, Lmo2, Fli1, Runx1, and Erg was tested
(by qRT-PCR) in V+ and V sorted cells (Figure 2C).
Gata2, Tal1, Lyl1, Lmo2, Runx1, and Fli1were significantly
higher in the day-6 V+ compared with V cells. At day 12,
Gata2, Tal1, Lyl1, and Lmo2were significantly higher in V+
compared with V cells. Similar expression levels of Erg
were found in V+ and V cells at day 6/day 12, and
Runx1 and Fli1 expression levels in these fractions were
similar at day 12. As a control, the expression of a non-
heptad ubiquitous transcription factor, Cbfb (Runx1 bind-
ing partner), was assessed (Figure S1I) and found to be
similarly expressed in day-6 V+ and V cells. Thus, the
expression of the relevant heptad hematopoietic tran-
scription factors in ESC-derived Gata2+ cells indicates a
developmental hematopoietic gene expression profile
consistent with that found in mouse embryos (Eich
et al., 2017).Figure 2. G2V Temporal Expression Defines Primitive and Definit
(A) Percentage of Venus+ (V+) cells in day 4–14 G2V ESC cultures (n =
(B) Relative Gata2 (left) and Gata1 (right) mRNA as measured in qRT-
days 4, 6, 8, 10, 12, and 14. Normalization to b-actin (n = 3).
(C) Relative Gata2, Tal1, Lyl1, Lmo2, Runx1, Fli1, and Erg mRNA as mea
(lower) of G2V ESC culture. Normalization to b-actin (n = 3).
(D) qRT-PCR analysis of relative Hbb-y (embryonic globin), bH1 (emb
differentiated ESCs at days 4, 6, 8, 10, 12, and 14. Normalization to
(E) Confocal images (representative) of whole-mount stained day-6
indicate flat endothelial-like V+ cells in day-6 EBs and round hemato
Magnification of whole-mount stained day-12 EB showing round V+ ce
40 mm.
(F) Bar graphs showing CFU-C per 104 V+ and V cells from day-6 a
monocyte-macrophage; CFU-GM, granulocyte-macrophage; CFU-M, m
EryP, primitive erythroid.
Data are shown as means ± SEM. *p < 0.05, **p < 0.01. See also FiguSequential Waves of Gata2+ Cells Correlate with
Functional Primitive and Definitive Hematopoietic
Potential
Hematopoiesis in the mouse embryo occurs in stage-spe-
cific waves, with the generation of cells with progressively
greater multipotent hematopoietic properties. To elucidate
whether V+ cells in the sequential waves express genes
indicative of primitive (Hbb-y and bH1; early erythroid)
and/or definitive (bmajor; adult erythroid) programs (Palis
et al., 2010; Sankaran et al., 2010), we performed qRT-
PCR (Figure 2D). Gata1 (pan-erythroid factor) showed
expression at days 6 to 14 (Figure 2B, right). Hbb-y was ex-
pressed from days 6 to 12 and decreased at day 14 (Fig-
ure 2D, upper), and bH1 expression was detected from
day 8 onward (Figure 2D, middle). Expression of both em-
bryonic globins preceded the onset of bmajor (adult globin)
expression that was detectable from day 10 onward (Fig-
ure 2D, lower), suggestive of definitive erythropoiesis.
In the mouse embryo, CD31+ HPCs/HSCs emerge from
CD31+ HECs (Boisset et al., 2010; Yokomizo et al., 2012).
CD31+, V+, and CD31+V+ cells were detected in day-6 and
day-12 embryoid bodies (EBs) (Figures 2E and 2E0). The
morphology and localization of V+ cells in CD31 immu-
nostained whole EBs was analyzed by confocal micro-
scopy. At day 6, CD31+ cells were dispersed throughout
the EBs with no distinct structural organization, and
flat endothelial-like V+CD31+ cells were found (Figure 2E).
At day 12, round hematopoietic-like V+CD31+ cells were
closely associated with the CD31+ cells lining the EB cav-
ities (Figures 2E [lower] and 2E0). These imaging data
indicate that V+ cells in the day-6 and day-12 EBs are
morphologically distinct, and thus may possess different
functions.
To test the relationship between Gata2 expression, stage
of differentiation, and hematopoietic function, we har-
vested cells from day-6, -12, and -14 EBs, sorted V+ andive Hematopoietic Stages of ESC Differentiation
3).
PCR analysis of differentiated (total unsorted) cells from G2V ESC at
sured in qRT-PCR analysis of V+ and V cells at days 6 (upper) and 12
ryonic globin), and bmajor (adult globin) mRNA of cells from G2V
b-actin (n = 3).
(upper) and day-12 (lower) EBs. Venus, green; CD31, red. Arrows
poietic-like V+ cells/clusters in day-12 EBs. Scale bars, 40 mm. (E0)
lls within the EB cavity close to CD31+ endothelial cells. Scale bar,
nd day-12 G2V ESCs (n = 3). CFU-GEMM, granulocyte-erythrocyte,
acrophage; CFU-G, granulocyte; BFU-E, definitive erythroid; CFU-
res S1 and S2.
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Figure 3. Temporal Phenotypic Analysis of Reporter ESC-Derived Cells during Hematopoietic Differentiation
(A–C) Percentage of C-KIT+ cells in total viable cells from differentiated (A) G2V (n = 6), (B) LG (n = 3), and (C) LGGV (day 6, n = 3; day 8 and
day 12, n = 4; day 10, n = 7; day 14, n = 5) ESCs at days 6, 8, 10, 12, and 14.
(D and E) Graphs showing the percentage of C-KIT+CD31+, C-KIT+CD41+, C-KIT+CD45+, and C-KIT+CD16/32+ cells in the reporter+ and re-
porter cells at days 6, 8, 10, 12, and 14. (D) G2V (V+, green; V, black; n = 3); (E) LG ESCs (G+, red; G, black; n = 4).
(legend continued on next page)
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V cells, and analyzedCFU-C.HPCswere found exclusively
in the V+ cell fractions (Figure 2F). Day-6 V+ cells gave rise
to 50.1 ± 13 CFU-C/104 cells (1 HPC:198 cells), whereas
day-12 V+ cells generated 36.0 ± 25 (1:278) and day-14 V+
cells 94.7 ± 20 CFU-C/104 cells (1:278). The majority
(67%) of day-6 cells had CFU-EryP potential. Only a low
frequency of macrophage, granulocyte, and definitive
erythroid (CFU-M, CFU-G, BFU-E) colonies were observed.
In contrast, day-12 and day-14 cells gave rise to a variety of
erythroid-myeloid colony types, includingmixedmultipo-
tent colonies (CFU-GEMM), suggesting that day-12, but
not day-6 V+ cells possess EMP potential. Moreover, the
day-14 progenitor frequency was increased 2.6-fold
compared with day 12, and more mixed multipotent
colonies were detected (Figure 2F). CFU-C derived from
day-12 to -14 progenitors exhibited significantly increased
proliferation capacity compared with the CFU-C from
day-6 EBs. Together these data indicate that Gata2+ cells
represent at least two different stages of induction in ESC
cultures that correlate with primitive and erythroid-
myeloid definitive functional cell potentials andmolecular
programs.
Gata2-Expressing C-KIT+ Cells Show Phenotypic
Markers Characteristic of Definitive Hematopoiesis
G2V ESCs were examined for C-KIT expression (marker of
cells undergoing transition to the hematopoietic lineage)
during the ESC differentiation culture. A high frequency
of C-KIT+ cells was found at day 6 (64%) and decreased
to 16% by days 10–14 (Figure 3A). The co-expression of
C-KIT with CD31 (endothelial and hematopoietic marker),
CD41 (HPC and megakaryocyte marker), CD45 (pan-he-
matopoietic), and CD16/32 (EMP marker co-expressed
with C-KIT) was measured together with Venus expression
on differentiated cells by FACS (Figures 3D and S3).
CD31+C-KIT+ cells were detected predominantly in V+ frac-
tion, whereas very few V cells showed this phenotype.
The percentages of CD31+C-KIT+ cells in the V+ fraction
increased steadily at days 6–10, with a low point at day
12, and then rose again, suggesting a late wave of hemato-
poietic emergence. Four percent of day-6 V+C-KIT+ cells
were CD41+ and this increased to 41% ± 3.3% at day 8, fol-
lowed by decreases at days 10–14. Interestingly, C-KIT was
mainly detected on V+CD41lo and not V+CD41hi cells, in
line with published data showing that AGM HP/SCs ex-
press CD41 at low/intermediate levels (Robin et al.,
2011). Very few V cells were CD41+ throughout all time
points analyzed, thus suggesting that co-expression of(F) Graphs showing the percentage of C-KIT+CD31+, C-KIT+CD41+, C-K
V+G (green) cell fractions of LGGV ESCs at days 10, 12, and 14 (n >
Data are shown as means ± SEM. Significant differences between repor
***p < 0.001, ****p < 0.0001. See also Figures S3, S4, S6, and S7.Gata2, CD41lo, and C-KIT define anHP/SC population dur-
ing ESCdifferentiation. CD45 expressionwas barely detect-
able in V+C-KIT+ cells at day 6 (1.3%). Therewas a profound
increase and peak at day 10 with 46% ± 2.2% of V+ cells
CD45+C-KIT+ (as compared with the peak of CD41+C-
KIT+ cells at day 8), and this was followed by decreased
CD45+C-KIT+ cell percentages at days 12 and 14. No
to very few V cells were CD45+C-KIT+ (0.4%–2.2%)
throughout the differentiation. Thus, CD45 is confirmed
as a later marker of hematopoietic cells. EMP markers
CD16/32 were highly expressed at day 10. Eighty-five
percent of day-10 V+C-KIT+ cells were CD16/32+, suggest-
ing that the erythroid-myeloid CFU-C potential detected
in the culture at days 12–14 emerges from CD16/32+V+
EMPs. In contrast to the other markers, CD16/32 was ex-
pressed also in V cells (15% ± 2.3% and 21% ± 5.0% at
day 6). This is expected and is in line with the in vivo results
showing Gata2-independent EMPs (Kaimakis et al., 2016).
When the viability of day-10 to -14 V+ cells was tested (Fig-
ure S1J) no profound change in cell viability was found,
indicating that the decreased frequency in phenotypic
HPCs is not related to cell death. Together, these data
demonstrate that Gata2 expression defines most pheno-
typic HPCs generated throughout ESC differentiation
(both early and later) and that these markers reveal wave-
like cell kinetics.
The LG Reporter Distinguishes a Late Hematopoietic
Wave with Multilineage Potential
Unlike G2V reporter embryos in which Gata2 expression
marks almost all hematopoietic cells from the earliest
time of generation, the SCA1 (LG) reporter in vivo is ex-
pressed in fewer hematopoietic cells and in cells generated
at later developmental stages (Boisset et al., 2010; de Bruijn
et al., 2002). Analysis of day-10 and day-14 G2V ESC cul-
tures showed respectively that 3.7% and 2.2% of cells ex-
pressed SCA1 (Figure 4A). Of the day-10 SCA1+ cells, less
than 1% were C-KIT+CD45+. Although a slightly higher
percentage of SCA1+ cells was found in day-10 cultures,
the day-14 cultures contained a 6-fold higher percentage
of C-KIT+CD45+ cells in the SCA1+ fraction, indicating
that the LG reporter may be a relevant tool to aid enrich-
ment for hematopoietic progenitors late in ESC differenti-
ation cultures.
An LG ESC line was established from the LG mouse
model to examine reporter expression kinetics during
ESC differentiation. FACS analysis (Figure 4B) showed the
presence of GFP+ (G+) cells already at days 3 (7%) and 4IT+CD45+ and C-KIT+CD16/32+ cells in V+G+ (blue), VG+ (red), and
3).
ter+ and reporter frequencies are indicated. *p < 0.05, **p < 0.01,
Stem Cell Reports j Vol. 10 j 151–165 j January 9, 2018 157
Figure 4. LG Expression Distinguishes
Functional Hematopoietic Cells in the
Definitive ESC Differentiation Stage
(A) FACS analysis of day-10 and day-14 G2V
ESC for SCA1+ cells. Percentages of SCA1+
and SCA1+C-KIT+CD45+ cells are indicated
(n = 3).
(B) Percentage of G+ cells in cultures of
differentiated LG ESCs at days 4–14 (n = 3).
(C) Blast colony (BL-CFC) potential in G+ and
G cells sorted from day-3 LG ESCs (n = 3).
(D) FACS dot plot showing percentage of
cells expressing FLK1 and/or GFP in day-3 LG
ESC cultures (n = 3).
(E) CFU-C potential of G+ and G cells
from LG ESC cultures harvested at days 7, 10,
12, and 14 (CFU-C/104; n = 4). Colony types
correspond to color code. CFU-GEMM, gran-
ulocyte, erythrocyte, monocyte, macro-
phage; CFU-GM, granulocyte-macrophage;
CFU-M, macrophage; CFU-G, granulocyte;
BFU-E, definitive erythroid; CFU-EryP, prim-
itive erythroid.
(F) Time course of CFU-C frequency in cul-
tures of LG ESC-derived G+ (red) and G
(black) cells at days 7, 10, 12, and 14. Sig-
nificant differences between CFU-C/104 G+
and G cells are indicated (n = 4).
(G) Lymphoid culture protocol used for dif-
ferentiation and enrichment of G+ cells from
LG ESCs.
(H) B-lymphoid marker CD19 and B220
FACS of day-14 + day-22 CD45+ cells and
CD19+B220+ (gated CD45+) cells from LG
lymphoid differentiation cultures.
Data are shown as means ± SEM. *p < 0.05,
**p < 0.01, ***p < 0.001. See Figure S5 for
percentage (n = 5) and controls.(10%), followed by a rapid 5-fold decrease. G+ cell percent-
ages increased at day 7 and peaked at days 9–10 of differen-
tiation (3-fold increase; 6% at day 10).
The percentage of C-KIT+ cells in cultures at days 6–14
averaged 17% with little change (Figure 3B), indicating
less efficient hematopoietic differentiation of the LG line
compared with G2V line (Figure 3A). Next, C-KIT and co-
expression of CD31, CD41, CD45, and CD16/32 within
the G+ and G fractions of day-6 to -14 LG ESC cultures
was determined (Figures 3E and S4). At day 6 the per-
centages of CD31+C-KIT+ cells in G+ and G fractions,
respectively (6.9% ± 0.4% and 6.9% ± 1.3%), were similar.
From day 10 onward, the percentage of CD31+C-KIT+ cells158 Stem Cell Reports j Vol. 10 j 151–165 j January 9, 2018increased in the G+ (rising to 26.0% ± 6.2%) comparedwith
the G fraction. CD41+C-KIT+ cells were detected begin-
ning at day 8 in G+ cells (0.9% ± 0.2%) and gradually
increased to 14% ± 3.0% at day 14. Percentages of
CD45+C-KIT+ showed a trend similar to that of CD41+C-
KIT+ cells and were detected in the G+ fraction from day 8
(0.2% ± 0.1%) onward. The frequency increased signifi-
cantly after day 12 and rose to 18% ± 5.1% at day 14. The
G fraction contained no to very few CD45+C-KIT+ cells.
C-KIT+CD16/32+ cells were detected from day 8 onward
in both G+ and G fractions, with the frequency of
C-KIT+CD16/32+ cells increasing considerably in the G+
fraction at days 10–12. These data indicate that LG reports
Figure 5. Late-Stage LGGV ESC Differentiation Cultures Contain
a High Frequency of HPCs in the Double Reporter-Positive
Population
(A) CFU-C/104 cells in day-12 (left; n = 6) and day-14 (right; n = 6)
V+G+, V+G, VG+, and VG fractions of differentiated LGGV ESCs.
Color code indicates colony type.
(B) FACS plots of viable reporter+ cells in day-12 (n = 8) and day-14
(n = 10) LGGV ESC differentiation cultures. Gated V+ (green), G+
(red), and V+G+ (blue) cells.
(C) Percentage of V+ (green), G+ (red), and V+G+ (blue) cells in the
total viable cells on days 6, 12, and 14 of LGGV ESC differentiation.
Data are shown as means ± SEM. ***p < 0.001, ****p < 0.0001. See
also Figure S6.phenotypic hematopoietic cells predominantly in the later
stages of ESC differentiation.
The relationship of GFP expression with hematopoietic
activity in the LG ESC culture was tested by blast colony-
forming assay. At early differentiation stages (day 3), signif-
icantly more blast colonies (BL-CFC) per 104 cells werefound in the G fraction (215 ± 11) than in the G+ fraction
(17 ± 12) (Figure 4C). Accordingly, very few FLK1+G+ cells
were found (1% ± 0.1%) (Figure 4D). CFU-C assays from
day-7 EBs revealed a small number of HPCs in both G+
and G fractions (Figure 4E). However, at days 12 and 14
significantly more CFU-Cs, including all the CFU-GEMMs,
were found in theG+ fraction. CFU-C frequencies increased
from day 7 to day 14 (Figures 4E and 4F) but were similar in
the G+ and G fractions at days 7 and 10. A significantly
higher frequency of CFU-C was in the G+ fraction than
the G fraction at day 12, and at day 14 virtually all CFU-Cs
were in the G+ fraction. This 2.3-fold increase in CFU-C fre-
quency from day 12 to ay 14 indicates that the LG reporter
enriches for late appearing HPCs.
To examinewhether late appearing cells have B-lymphoid
potential, we co-cultured day-14 LG EB-derived G+ cells for
22 days on OP-9 cells with lymphoid-promoting factors
(Figure 4G). FACS analysis of B cell markers CD19 and
B220 revealed that 4.3% ± 0.6% of the cells were
CD19+CD45+ and 4.9% ± 0.8% were B220+CD45+. Seven
percent of CD45+ were positive for both CD19 and B220
(Figures 4H and S5). Thus, some LG reporter-expressing cells
possess B-lymphoid potential.
Double Reporter Expression Defines Most HPCs in
Late-Stage ESC Differentiation
To assess whether G2V and LG reporter expression is
overlapping, we established a Ly6a(SCA1)GFP:Gata2Venus
(LGGV) double ESC reporter line and examined the kinetics
and frequency of reporter-expressing hematopoietic cells
during differentiation (Figures S6, 5B, and 5C).
The efficiency of LGGV ESC hematopoietic differentia-
tion was determined by C-KIT FACS analysis at days 6, 8,
10, 12, and 14 (Figure 3C). The percentage of C-KIT+ cells
in the total viable cell population of day-6 and -8 LGGV cul-
tures was 37% and 34% respectively. At days 10–14, the cul-
tures contained an average of 18% C-KIT+, thus indicating
that the temporal hematopoietic differentiation efficiency
of the LGGV line is similar to that of the G2V line (Fig-
ure 3A). Next, analysis for co-expression of C-KIT and
CD31, CD41, CD45, or CD16/32 within the V+G+, V+G,
and VG+ fractions of day-10, -12, and -14 ESC differentia-
tion cultures was performed (Figures 3F and S7). In general,
the highest percentage of C-KIT+CD31+, C-KIT+CD41+,
C-KIT+CD45+, and C-KIT+CD16/32+ cells was in the V+G+
fraction at all three time points. Moreover, at day 14 for
all the markers except for C-KIT+CD41+, significant in-
creases in the percentages of marker-positive cells were
found in the V+G+ fraction as compared with the V+G
and/or VG+ fractions, indicating a late shift in phenotypic
hematopoietic progenitors.
To determine in which reporter-expressing popula-
tions HPC function was localized, we differentiatedStem Cell Reports j Vol. 10 j 151–165 j January 9, 2018 159
Figure 6. Temporal Distribution of He-
matopoietic Progenitors in Reporter ESC
Differentiation Cultures
(A) Percentage of CFU-C/104 cells in day-6,
-12, and -14 differentiated G2V ESC-derived
V+ cells (green) (upper); in day-7, -12, and
-14 differentiated LG ESC-derived G+ (red)
and G cells (white) (middle); and in day-12
and -14 differentiated LGGV ESC-derived
V+G+ (blue) and V+ cells (green) (lower).
CFU-C frequencies are calculated based on
the percentage of respective reporter-ex-
pressing cells in the total population.
(B) Time-course model showing waves of
primitive, erythroid-myeloid-definitive, and
B-lymphoid-definitive hematopoietic pro-
genitor activities in multireporter ESC dif-
ferentiation cultures.LGGV ESCs, and analyzed day-12 and day-14 single
(V+G and VG+) and double (V+G+) reporter-expressing
cells along with reporter-negative (VG) cells (Fig-
ure 5A). At day 12, 119 CFU-C/104 were detected, of
which 57 were derived from V+G and 62 from V+G+
fractions. Negligible to no CFU-Cs were present in the
VG+ or VG fractions. The CFU-C frequency at day
14 increased to 200/104 cells, and all CFU-GEMM were
in the V+G+ fraction (Figure 5A). Interestingly, when tak-
ing into account the frequency of reporter-expressing
cells in the total cell population derived from LGGV
EBs (Figures 5A and 5B), overall CFU-C frequency in
the day-14 V+G+ versus V+G fraction increased 4-fold
(from 5% to 20% of the total colonies) compared with
day 12 (Figure 6A, lower). This is in line with the in-
crease in CFU-C frequency in the G+ versus G fractions
derived from day-12 and day-14 LG cultures (Figure 6A,
middle). Colonies derived from G2V cultures were found
only within the V+ fraction throughout differentiation
(Figure 6A, upper).
Together, these data suggest that a subset of progenitors
is generated and/or gradually acquires the LG marker later
in the culture and possesses more complex hematopoietic
potential, thereby distinguishing and allowing specific
enrichment of a more potent definitive wave of ESC he-
matopoietic emergence.160 Stem Cell Reports j Vol. 10 j 151–165 j January 9, 2018DISCUSSION
In this study, we show that ESC differentiation progresses
through stages of functional hematopoietic cell production
that can be discriminated by the G2V and/or LG reporters
(Figure 6B). The fact that these reporters are validated in vivo
indicators of normal temporal and spatial generation of
functional hematopoietic cells in the mouse embryo (de
Bruijn et al., 2002; Kaimakis et al., 2016; Li et al., 2014; Sol-
aimani Kartalaei et al., 2015) ensures high fidelity in their
use to examine the stages of hematopoietic emergence
in vitro. The reporter-expressing ESC-derived cells exhibit
functional hematopoietic properties that correspond to cells
generated in the in vivo waves of hematopoietic emergence.
Hematopoiesis in themouse embryo starts in the YS with
a transient wave of primitive hematopoiesis, and is charac-
terized by FLK1+ cells that give rise to the earliest blood cells
and endothelium (Choi et al., 1998; Kennedy et al., 1997;
Palis et al., 1999; Shalaby et al., 1997). Our analysis of early
G2V EB differentiation (days 4–6) reveals a transient
FLK1+V+ population that differentiates into endothelial
and/or primitive erythroid cells. In contrast, early LG EB
differentiation shows that most FLK1 expression is in the
G cell fraction and blast colony-forming activity is in
the FLK+ andG cell fraction. Thus,G2V but not LG reports
the earliest onset of hematopoietic potential in ESCs.
V+ cells, albeit very few, are alreadypresent at day 4 ofG2V
ESC differentiation. It was difficult to detect Gata2, Gata1,
and globin gene expression at day 4 (Figure 2B) by qRT-
PCR of total G2V EB RNA. Others have shown, by single
cell transcriptomics performed on pseudotemporally or-
dered E7.5–7.75 FLK1+ mesodermal cells, an upregulation
of Gata1, bH1, and Itga2b (CD41) following Brachyury
expression during primitive streak specification (Scialdone
et al., 2016). In total EB RNA,we found Brachyury expression
at days 3 and 6 (Figure S1H), indicating that at least some
differentiating EBs closely follow the formation of early
mesoderm ingastrulating embryos.Gata1 andGata2 expres-
sion was initiated at days 4–6. Embryonic globin Hbby and
bH1 expression began at days 4–6 and 6–8, respectively,
andadult globin (bmajor) expressionbeganatdays8–10 (Fig-
ure 2D) although its levelswere relatively low. These data are
somewhat in agreement with those found in themouse em-
bryo (Sankaran et al., 2010). bH1 expression begins in the YS
at E7.5 (Kingsley et al., 2006), with only very low levels of
Hbby and bmajor expression. Hbby expression is high in the
E10.5 and E15.5 peripheral blood, and bmajor expression is
high in the enucleated E15.5 erythrocytes. Thus, while the
general onset of expression of the embryonic globins prior
tobmajor expression is similar to in vivo expression, theother
differences seen in the ESC differentiation cultures are likely
due to heterogeneous cell growth and frequency.
Interestingly, a decreased frequency of CFU-EryP in the
V+ fraction corresponded with the onset of the second
Gata2 expression wave at days 10–11 that is accompanied
by expression of adult globin and the appearance of
EMPs (Figure 2F). Thus, the Gata2 expression peaks
discriminate functional primitive and definitive stages in
the ESC differentiation. It is likely that these waves derive
from independent cohorts of cells as supported by tran-
scriptomic (Scialdone et al., 2016) and hESC differentiation
data (Ditadi et al., 2015; Sturgeon et al., 2014), but contrasts
with data suggesting that all waves of hematopoietic activ-
ity and in vivo repopulating cells arise as early as day 3 (Pear-
son et al., 2015). Additionally, the temporal dynamics of
Gata2-defined primitive/definitive stages are consistent
with studies reporting hemogenic endothelium and he-
matopoietic cell generation in mouse ESC and hESC differ-
entiation cultures (Nakano et al., 1996; Ng et al., 2016;
Zambidis et al., 2005). Although all CFU-Cs were obtained
in the V+ cell fraction, FACS analysis revealed some pheno-
typic HPCs in the V fraction. Hence, we cannot rule out
that some early HPCs may be at low frequency in the V
fraction as was found in vivo (Kaimakis et al., 2016).
Morphological observation of V+ cells in the differenti-
ating EBs corroborates both developmental and functional
stage changes. Day-12 (but not day-6) EBs showCD31+ cells
lining vascular tubules and the close association of clusters
of V+CD31+ cells, mainly near the EB cavities (Figures 2Eand 2E0). This is supported by FACS data showing an
increased frequencyofC-KIT+CD31+V+ cells after day6 (Fig-
ure 3D). Most probably it represents the EHT detected in
E8.25–11 circulation-deficient YS where EMPs emerge in
C-KIT+ cell clusters (Frame et al., 2016). Although a recent
study with day-23 to -33 differentiated hESCs showed
similar aortic and cluster-like structures (Ng et al., 2016), it
as yet uncertain, due to the heterogeneity of our cultures,
whether they contain the CD31+V+ aortic endothelial and
CD31+C-KIT+V+ intra-aortic hematopoietic cluster cells
equivalent to E10.5G2VAGM tissue (Kaimakis et al., 2016).
Surfacemarker analysis ofG2V ESC-derived cells revealed
that the highest frequency of phenotypic V+C-KIT+CD41+
hematopoietic cells is at day 8, whereas V+C-KIT+CD45+,
V+C-KIT+CD16/32+, and V+C-KIT+CD31+ cells peak at day
10 (Figure 3D). Thereafter their frequency is greatly
reduced. These dynamics may reflect early stages of
myeloid differentiation. However, our FACS data (not
shown) indicate that the differentiated blood cells are
within the V cell compartment, supporting the view
that the V+ cell waves reflect different progenitor emer-
gence stages. This is in line with several hESC expression
profiling and surface marker studies that suggest waves of
hematopoietic generation followed by blood cell matura-
tion (Irion et al., 2010; Nakano et al., 1996; Zambidis
et al., 2005). Thus, the second wave of ESC V+ hematopoi-
etic cell production functionally, morphologically, and
phenotypically resembles in vivo definitive hematogenesis
in the YS.
HPC potential in our ESC differentiation cultures con-
tinues at day 12 and thereafter, and LG reporter expression
identifies all definitive HPCs at these late time points. LG
did not enrich for primitive stage blast-cell progenitors,
nor for HPCs during the first stage of EB differentiation
(e.g., days 6–10). This contrasts with G2V ESCs where all
HPCs are V+ throughout the differentiation. From day 12
onward, HPC activity is significantly enriched in G+ frac-
tion, and at day 14 someG+ cells possess B-lymphoid poten-
tial. Distribution of HPC activity in the LG EBs is consistent
with the distribution in the LG mouse embryos. In the LG
YS, most HPCs are G whereas AGM lymphoid progenitors
at E10 and multipotent HPCs/HSC are at much higher fre-
quency in the E10.5/11.5 G+ than in the G fraction (de
Bruijn et al., 2002; Li et al., 2014; Solaimani Kartalaei
et al., 2015). In the E10.5 aorta, LG expression reports hemo-
genic endothelial cells transitioning to HSCs (Boisset et al.,
2010). Thus, LG expression in vivo specifically reports aortic
HSCs and cells with lymphoid potential, but not the YS-
stage progenitors. Although there is consistency between
our in vitro LG ESC results and in vivo LG mouse data, it is
as yet uncertain whether the ESC-derived definitive G+ pro-
genitors that have B-lymphoid potential represent an aorta-
like or YS-definitive program, as lymphoid potential has alsoStem Cell Reports j Vol. 10 j 151–165 j January 9, 2018 161
been demonstrated in the YS independently from arterial
identity (Frame et al., 2016; Yoshimoto et al., 2011).
Importantly, our LGGV double reporter ESC line shows
that these late G+ HPC co-express Gata2, thus facilitating
high enrichment of multipotent progenitors that are
generated in late ESC differentiation cultures. In some pre-
liminary short-term transplantation experiments (4 3 104
V+ cells from day-12 or -14 differentiated G2V ESCs) we
were unable to detect donor-derived spleen colonies.
Such short-term and long-term transplantation experi-
ments with the LGGV ESC line are planned after further
optimization of the differentiation cultures and flow-cyto-
metric enrichment.
In conclusion, we demonstrate that different stages of
HPC generation can be prospectively isolated by the G2V
and/or LG reporter expression in ESC differentiation cul-
tures. Such findings facilitate a better understanding of
the hematopoietic development in ESC differentiation cul-
tures, and should ultimately enable the recapitulation of
robust physiologic HSC emergence for the de novo genera-
tion of transplantable HSCs.EXPERIMENTAL PROCEDURES
ESC In Vitro Differentiation
ESCs (WT, G2V, LG, LGGV) were established from 129/Ola,
Gata2Venus (Kaimakis et al., 2016), Ly6a(SCA1)GFP (de Bruijn
et al., 2002), and (Gata2Venus 3 Ly6a(SCA1)GFP)F1 day-3.5 blasto-
cysts cultured on irradiated mouse embryonic fibroblasts (MEFs) in
SR-ES medium (KO DMEM + 20% KO Serum Replacement + 1%
penicillin/streptomycin [P/S] + 2 mM L-glutamine + 13 non-essen-
tial amino acids [NEAA] [all Gibco] + 100 mM b-mercaptoethanol
[Sigma] + recombinant mouse leukemia inhibitory factor [LIF;
1,000 U/mL; Chemicon International]). To allow for inner cell
mass expansion the medium was changed every 2 days and cells
were trypsinized, transferred to 12-well MEF-coated plates, and
maintained in DMEM (Lonza) + 15% fetal bovine serum (FBS;
HyClone) + 2 mM GlutaMAX + 1 mM Na-pyruvate + 1% P/S +
50 mM b-mercaptoethanol (all Gibco) + 0.1 mM NEAA (Lonza) +
1,000 U/mL LIF (Sigma) at 37C and 5% CO2. MEFs were depleted
by 30-min incubation in EB medium (Iscove’s modified Dulbecco’s
medium[IMDM]+15%fetal calf serum[HyClone]+1%P/S [Gibco]).
EB formation was induced (40 rpm; 25 3 103 cells/mL) in EB me-
dium+2mMGlutaMAX (Gibco) + 50 mg/mL ascorbic acid (Sigma) +
4 3 104 M monothioglycerol (Sigma) + 300 mg/mL transferrin
(Roche) and supplemented with 5% proteome-free hybridoma me-
dium (Gibco) on day 3. From day 6 onward, 100 ng/mL stem cell
factor (SCF) + 1 ng/mL interleukin-3 (IL-3) + 5 ng/mL IL-11
were added. For blast-cell cultures, 5 ng/mL BMP4 was added on
days 0–3. All factors were from PeproTech.
FACS
PBS-washed EBs were incubated (37C, 3–5min) in TrypLE Express
(Gibco). PBS + 10% FBS + 1% P/S was added and single cells sus-
pended (P1000 pipette). 106 cells per 100 mL were immunostained162 Stem Cell Reports j Vol. 10 j 151–165 j January 9, 2018(30min on ice) (Table S1). Dead cells were Hoechst 33342 (Invitro-
gen) excluded. LSRFortessa, FACScan, FACSAria III/Fusion (Becton
Dickinson) and FlowJo software (TreeStar) were used. Strategy for
detection of GFP and/or Venus is described in Supplemental Exper-
imental Procedures and Figure S6.
CFU-C Assays
For BL-CFC, day-3 EB cells were plated in methylcellulose
(STEMCELL Technologies) + 10% FCS + vascular endothelial
growth factor (5 ng/mL) + IL-6 (10 ng/mL) (PeproTech). After
4 days, BL-CFC (grape-like multicellular structures [Kennedy
et al., 2007]) were microscopically counted. D6-14 EB cells
were plated in methylcellulose (1 mL/dish, M3434; STEMCELL
Technologies) + IMDM + FBS + BSA + recombinant human insu-
lin + human transferrin (iron-saturated) + 2-mercaptoethanol +
recombinant SCF + recombinant IL-3 + recombinant IL-6 + re-
combinant human erythropoietin. After 12–14 days, colonies
were scored (Zeiss Axiovert25).
Matrigel Assay
Day-4 EB cells (23 104) from each FLK1/Venus fraction (Figure 1B)
were pre-cultured in gelatin-coated 96-well plates (DMEM + 20%
FBS + 1% P/S; 20 hr). Cells were trypsinized, transferred to Matri-
gel-coated (60 mL Matrigel/well, 30 min, 37C; Qiagen) 96-well
plates and cultured in EGM-2 (Lonza) for 4 hr. Tubules were quan-
tified by the Angiogenesis Analyzer (Gilles Carpentier ImageJ
News, 2012) plugin for Fiji.
Transcription Analysis
Up to 106 cells were lysed and total RNA isolated (TRI-Reagent,
MRC). RNA (1 mg) wasDNase (Invitrogen) treated. RNA from sorted
cells was isolated using an RNeasy kit (Qiagen). cDNA was synthe-
sized with oligo(dT) (Invitrogen) and SuperScriptIII (Life Technol-
ogies). qRT-PCR was performed with FastSybrGreen master mix
(Life Technologies) and primers (Table S2).
B-Lymphoid Culture
At day 6 of ESC differentiation, 100 ng/mL SCF + 1 ng/mL IL-3 +
5 ng/mL IL-11 + 5 ng/mL FLT3L were added and medium replaced
every other day. On day 14, EBs were dissociated and 5–10 3 104
FACS-sorted cells plated onOP9 (plated at1 day in a 6-well plate)
in 2mL of a-minimal essentialmedium+ 20% FBS + 1% P/S + 5 ng/
mL IL-7 + 5 ng/mL FLT3L. Every 4–6 days, cells were replated on
OP9 and harvested on day 22. The FACS strategy is displayed in
Figure S5.
Whole-Mount Staining
EB staining was performed as in Yokomizo et al. (2012). EBs were
washed in PBS, fixed in PBS + 2% paraformaldehyde (Sigma) for
10 min, washed in PBS (33), and dehydrated in 50% methanol +
PBS and 100% methanol (10 min, 32). EBs were rehydrated in
1:1 methanol/PBS (10 min) and 100% methanol (10 min),
washed in PBS (10 min on ice), and blocked in PBS + 1% semi-
skimmed milk + 0.005% Tween 20 (Sigma) (PBS-MT) + 10%
BSA (Sigma) + 0.1% goat serum (4–6 hr). Antibody (Table S1)
staining was performed (4C) in PBS-MT and EBs washed in
PBS-MT (>2 hr 33), in 100% methanol (30 s, 34) in a fast well,
cleared in 1:1 benzyl alcohol benzyl benzoate (BABB)/methanol
(30 s) followed by 100% BABB, overlaid with a coverslip, and
imaged (Leica SP5).
Statistics
Unpaired Student’s t test or one-way ANOVA with Bonferroni
correction formultiple comparisonswere used (GraphPad). Results
were statistically significant at p < 0.05 (*p < 0.05, **p < 0.01, ***p <
0.001 in figures). All data are shown as mean ± SEM. n denotes the
number of biological replicates.
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Procedures, seven figures, and two tables and can be found with
this article online at https://doi.org/10.1016/j.stemcr.2017.11.
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